semaglutide news november 2025 Novo Nordisk Alzheimer's drug trials fail in blow to weight-loss giant What the Obesity Drugmakers Expect

Federal Ozempic vision loss lawsuits and gastrointestinal injury cases have been consolidated into multidistrict litigation in the Eastern District of Pennsylvania, where plaintiffs allege the manufacturers minimized or delayed warnings about these severe injuries despite emerging safety reports and adverse event data

TRIUMPH-2: Ongoing (obesity + type 2 diabetes) results expected Q3Q4 2026

L-karnityna jest jakby wewntrznym programem treningowym

Eat what you can tolerate

Abstract Consumption of cannabis is on the rise as public opinion trends toward acceptance and its consequent legalization

Unlike broad systemic compounds, GHK-Cu peptide provides a localized research model